Levent Elmas

540 total citations
24 papers, 426 citations indexed

About

Levent Elmas is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Levent Elmas has authored 24 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Immunology. Recurrent topics in Levent Elmas's work include Bioactive natural compounds (3 papers), interferon and immune responses (2 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). Levent Elmas is often cited by papers focused on Bioactive natural compounds (3 papers), interferon and immune responses (2 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). Levent Elmas collaborates with scholars based in Türkiye, Cyprus and Kuwait. Levent Elmas's co-authors include Yavuz Dodurga, Mücahit Seçme, Vildan Caner, Aydin Akçılar, Raziye Akçılar, Sebahat Turgut, Ceylan Ayada, Çığır Biray Avcı, Canan Eroğlu Güneş and N. Lale Şatıroğlu-Tufan and has published in prestigious journals such as Gene, Journal of Cellular Biochemistry and Journal of Surgical Research.

In The Last Decade

Levent Elmas

24 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levent Elmas Türkiye 12 179 105 76 57 53 24 426
In‐Sook Ahn South Korea 10 275 1.5× 148 1.4× 63 0.8× 74 1.3× 100 1.9× 22 657
Choon‐Sik Jeong South Korea 11 235 1.3× 72 0.7× 59 0.8× 23 0.4× 42 0.8× 24 492
Samantha Orr United Kingdom 7 265 1.5× 95 0.9× 74 1.0× 36 0.6× 33 0.6× 10 610
Yun-Sil Lee South Korea 5 232 1.3× 64 0.6× 31 0.4× 40 0.7× 99 1.9× 6 496
Yuan Yue China 6 192 1.1× 79 0.8× 29 0.4× 40 0.7× 31 0.6× 9 568
Ching‐Fen Wu Germany 15 201 1.1× 56 0.5× 46 0.6× 20 0.4× 35 0.7× 19 475
Qingfeng Xie China 12 222 1.2× 67 0.6× 42 0.6× 20 0.4× 21 0.4× 20 547
Soha Osama Hassanin Egypt 16 214 1.2× 63 0.6× 23 0.3× 40 0.7× 20 0.4× 25 622
Marco Maina Italy 10 222 1.2× 37 0.4× 175 2.3× 35 0.6× 76 1.4× 10 550
Maliheh Moradzadeh Iran 12 201 1.1× 83 0.8× 29 0.4× 38 0.7× 96 1.8× 18 486

Countries citing papers authored by Levent Elmas

Since Specialization
Citations

This map shows the geographic impact of Levent Elmas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levent Elmas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levent Elmas more than expected).

Fields of papers citing papers by Levent Elmas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levent Elmas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levent Elmas. The network helps show where Levent Elmas may publish in the future.

Co-authorship network of co-authors of Levent Elmas

This figure shows the co-authorship network connecting the top 25 collaborators of Levent Elmas. A scholar is included among the top collaborators of Levent Elmas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levent Elmas. Levent Elmas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dodurga, Yavuz, Levent Elmas, Mücahit Seçme, et al.. (2024). Investigation of the Apoptotic and Cell Cycle Effects of Sorafenib and Doxorubicin on URG4/URGCP in Leukemia Cells. Pamukkale Medical Journal. 1 indexed citations
2.
3.
4.
Taşkın, Mine İslimye, et al.. (2022). The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis. Reproductive Biology and Endocrinology. 20(1). 95–95. 24 indexed citations
5.
Güneş, Canan Eroğlu, et al.. (2022). Glycoside oleandrin downregulates toll-like receptor pathway genes and associated miRNAs in human melanoma cells. Gene. 843. 146805–146805. 7 indexed citations
6.
Seçme, Mücahit, et al.. (2022). Erianin, a promising agent in the treatment of glioblastoma multiforme triggers apoptosis in U373 and A172 glioblastoma cells. Archives of Biological Sciences. 74(3). 227–234. 4 indexed citations
7.
8.
Taşpınar, Mehmet, Alihan Bozoğlan, Abdullah Seçkin Ertuğrul, & Levent Elmas. (2020). The role of HBD-2, HBD-3, and calprotectin in the relationshipbetween chronic periodontitis and atherosclerosis. Biocell. 44(3). 337–344. 1 indexed citations
9.
Taşkın, Mine İslimye, et al.. (2020). Granzyme B levels and granzyme B polymorphisms in peripheral blood of patients with endometriosis: a preliminary study. Journal of Obstetrics and Gynaecology. 41(1). 94–99. 5 indexed citations
10.
11.
Elmas, Levent, et al.. (2017). Human TLR gene family members are differentially expressed in patients with urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 35(12). 674.e11–674.e17. 4 indexed citations
12.
Balkarlı, Ayşe, et al.. (2016). MEFV gene variation R202Q is associated with metabolic syndrome.. PubMed. 20(15). 3255–61. 2 indexed citations
13.
Dodurga, Yavuz, et al.. (2016). Anti-tumor effects of bemiparin in HepG2 and MIA PaCa-2 cells. Gene. 585(2). 241–246. 11 indexed citations
14.
Güçlü, Aydın, Cengiz Koçak, Fatma Emel Koçak, et al.. (2016). MicroRNA-125b as a new potential biomarker on diagnosis of renal ischemia–reperfusion injury. Journal of Surgical Research. 207. 241–248. 17 indexed citations
15.
Dodurga, Yavuz, et al.. (2015). Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells. Tumor Biology. 37(2). 2647–2653. 28 indexed citations
16.
17.
Dodurga, Yavuz, Canan Eroğlu Güneş, Mücahit Seçme, et al.. (2015). Anti-proliferative and anti-invasive effects of ferulic acid in TT medullary thyroid cancer cells interacting with URG4/URGCP. Tumor Biology. 37(2). 1933–1940. 33 indexed citations
18.
Akçılar, Raziye, Sebahat Turgut, Vildan Caner, et al.. (2013). Apelin Effects on Blood Pressure and RAS in DOCA-Salt-Induced Hypertensive Rats. Clinical and Experimental Hypertension. 35(7). 550–557. 38 indexed citations
19.
Caner, Vildan, et al.. (2011). Expression of ERCC1 and its clinicopathological correlations in non-small cell lung cancer. Molecular Biology Reports. 39(1). 335–341. 9 indexed citations
20.
Caner, Vildan, et al.. (2011). Determination of O 6 -Methylguanine DNA Methyltransferase Promoter Methylation in Non-Small Cell Lung Cancer. Genetic Testing and Molecular Biomarkers. 15(5). 357–360. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by In‐Sook Ahn Breakdown of academic impact, for papers by Choon‐Sik Jeong Breakdown of academic impact, for papers by Samantha Orr Breakdown of academic impact, for papers by Yun-Sil Lee Breakdown of academic impact, for papers by Yuan Yue Breakdown of academic impact, for papers by Ching‐Fen Wu Breakdown of academic impact, for papers by Qingfeng Xie Breakdown of academic impact, for papers by Soha Osama Hassanin Breakdown of academic impact, for papers by Marco Maina Breakdown of academic impact, for papers by Maliheh Moradzadeh
Rankless by CCL
2026